572 related articles for article (PubMed ID: 18521080)
21. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.
Sun K; Wang W; Zeng JJ; Wu CT; Lei ST; Li GX
Acta Pharmacol Sin; 2011 Mar; 32(3):375-84. PubMed ID: 21278784
[TBL] [Abstract][Full Text] [Related]
24. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
[TBL] [Abstract][Full Text] [Related]
25. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
[TBL] [Abstract][Full Text] [Related]
26. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Maurel M; Jalvy S; Ladeiro Y; Combe C; Vachet L; Sagliocco F; Bioulac-Sage P; Pitard V; Jacquemin-Sablon H; Zucman-Rossi J; Laloo B; Grosset CF
Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
[TBL] [Abstract][Full Text] [Related]
27. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
[TBL] [Abstract][Full Text] [Related]
28. miR-25 promotes glioma cell proliferation by targeting CDKN1C.
Zhang J; Gong X; Tian K; Chen D; Sun J; Wang G; Guo M
Biomed Pharmacother; 2015 Apr; 71():7-14. PubMed ID: 25960208
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.
le Sage C; Nagel R; Egan DA; Schrier M; Mesman E; Mangiola A; Anile C; Maira G; Mercatelli N; Ciafrè SA; Farace MG; Agami R
EMBO J; 2007 Aug; 26(15):3699-708. PubMed ID: 17627278
[TBL] [Abstract][Full Text] [Related]
30. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma.
Chung GE; Yoon JH; Myung SJ; Lee JH; Lee SH; Lee SM; Kim SJ; Hwang SY; Lee HS; Kim CY
Oncol Rep; 2010 Jan; 23(1):113-9. PubMed ID: 19956871
[TBL] [Abstract][Full Text] [Related]
31. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
[TBL] [Abstract][Full Text] [Related]
32. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
Huang N; Lin J; Ruan J; Su N; Qing R; Liu F; He B; Lv C; Zheng D; Luo R
FEBS Lett; 2012 Mar; 586(6):884-91. PubMed ID: 22449976
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
[TBL] [Abstract][Full Text] [Related]
34. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.
Gramantieri L; Fornari F; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Croce CM; Bolondi L; Negrini M
Clin Cancer Res; 2009 Aug; 15(16):5073-81. PubMed ID: 19671867
[TBL] [Abstract][Full Text] [Related]
36. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
Yang CJ; Shen WG; Liu CJ; Chen YW; Lu HH; Tsai MM; Lin SC
J Oral Pathol Med; 2011 Aug; 40(7):560-6. PubMed ID: 21226887
[TBL] [Abstract][Full Text] [Related]
37. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
39. [Effects of α-pinene extracted from pine needle on expression of miR-221 and its potential target genes in human hepatocellular carcinoma cells].
Yang JB; Li M; Xie JJ; Yang MD; Lu XS; Wang F; Chen WQ
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):3996-3999. PubMed ID: 28929687
[TBL] [Abstract][Full Text] [Related]
40. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
